|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Brawner KM, Morrow CD and Smith PD:
Gastric microbiome and gastric cancer. Cancer J. 20:211–216. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chiu PW, Teoh AY, To KF, Wong SK, Liu SY,
Lam CC, Yung MY, Chan FK, Lau JY and Ng EK: Endoscopic submucosal
dissection (ESD) compared with gastrectomy for treatment of early
gastric neoplasia: A retrospective cohort study. Surg Endosc.
26:3584–3591. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kamat AM: Commentary on ‘Phase II trial of
cetuximab with or without paclitaxel in patients with advanced
urothelial tract carcinoma.’ Wong YN, Litwin S, Vaughn D, Cohen S,
Plimack ER, Lee J, Song W, Dabrow M, Brody M, Tuttle H, Hudes G,
University of Pennsylvania, Philadelphia, PA: J Clin Oncol
2012;30(28):3545-51 [Epub 2012 Aug 27]. Urol Oncol. 31:7192013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Perk J, Iavarone A and Benezra R: Id
family of helix-loop-helix proteins in cancer. Nat Rev Cancer.
5:603–614. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Benezra R, Davis RL, Lockshon D, Turner DL
and Weintraub H: The protein Id: A negative regulator of
helix-loop-helix DNA binding proteins. Cell. 61:49–59. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yates PR, Atherton GT, Deed RW, Norton JD
and Sharrocks AD: Id helix-loop-helix proteins inhibit
nucleoprotein complex formation by the TCF ETS-domain transcription
factors. EMBO J. 18:968–976. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ling MT, Wang X, Zhang X and Wong YC: The
multiple roles of Id-1 in cancer progression. Differentiation.
74:481–487. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ding Y, Wang G, Ling MT, Wong YC, Li X, Na
Y, Zhang X, Chua CW, Wang X and Xin D: Significance of Id-1
up-regulation and its association with EGFR in bladder cancer cell
invasion. Int J Oncol. 28:847–854. 2006.PubMed/NCBI
|
|
11
|
Wilson JW, Deed RW, Inoue T, Balzi M,
Becciolini A, Faraoni P, Potten CS and Norton JD: Expression of Id
helix-loop-helix proteins in colorectal adenocarcinoma correlates
with p53 expression and mitotic index. Cancer Res. 61:8803–8810.
2001.PubMed/NCBI
|
|
12
|
Luo KJ, Wen J, Xie X, Fu JH, Luo RZ, Wu QL
and Hu Y: Prognostic relevance of Id-1 expression in patients with
resectable esophageal squamous cell carcinoma. Ann Thorac Surg.
93:1682–1688. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang HY, Liu HL, Liu GY, Zhu H, Meng QW,
Qu LD, Liu LX and Jiang HC: Expression and prognostic values of
Id-1 and Id-3 in gastric adenocarcinoma. J Surg Res. 167:258–266.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Gautschi O, Tepper CG, Purnell PR, Izumiya
Y, Evans CP, Green TP, Desprez PY, Lara PN, Gandara DR, Mack PC and
Kung HJ: Regulation of Id1 expression by SRC: Implications for
targeting of the bone morphogenetic protein pathway in cancer.
Cancer Res. 68:2250–2258. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lasorella A, Boldrini R, Dominici C,
Donfrancesco A, Yokota Y, Inserra A and Iavarone A: Id2 is critical
for cellular proliferation and is the oncogenic effector of N-myc
in human neuroblastoma. Cancer Res. 62:301–306. 2002.PubMed/NCBI
|
|
16
|
Reynaud-Deonauth S, Zhang H, Afouda A,
Taillefert S, Beatus P, Kloc M, Etkin LD, Fischer-Lougheed J and
Spohr G: Notch signaling is involved in the regulation of Id3 gene
transcription during Xenopus embryogenesis. Differentiation.
69:198–208. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tam WF, Gu TL, Chen J, Lee BH, Bullinger
L, Fröhling S, Wang A, Monti S, Golub TR and Gilliland DG: Id1 is a
common downstream target of oncogenic tyrosine kinases in leukemic
cells. Blood. 112:1981–1992. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Birkenkamp KU, Essafi A, van der Vos KE,
da Costa M, Hui RC, Holstege F, Koenderman L, Lam EW and Coffer PJ:
FOXO3a induces differentiation of Bcr-Abl-transformed cells through
transcriptional down-regulation of Id1. J Biol Chem. 282:2211–2220.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Paolella BR, Havrda MC, Mantani A, Wray
CM, Zhang Z and Israel MA: p53 directly represses Id2 to inhibit
the proliferation of neural progenitor cells. Stem Cells.
29:1090–1101. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ponz-Sarvisé M, Nguewa PA, Pajares MJ,
Agorreta J, Lozano MD, Redrado M, Pio R, Behrens C, Wistuba II,
García-Franco CE, et al: Inhibitor of differentiation-1 as a novel
prognostic factor in NSCLC patients with adenocarcinoma histology
and its potential contribution to therapy resistance. Clin Cancer
Res. 17:4155–4166. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hollnagel A, Oehlmann V, Heymer J, Rüther
U and Nordheim A: Id genes are direct targets of bone morphogenetic
protein induction in embryonic stem cells. J Biol Chem.
274:19838–19845. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
O'Brien CA, Kreso A, Ryan P, Hermans KG,
Gibson L, Wang Y, Tsatsanis A, Gallinger S and Dick JE: ID1 and ID3
regulate the self-renewal capacity of human colon cancer-initiating
cells through p21. Cancer Cell. 21:777–792. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nam HS and Benezra R: High levels of Id1
expression define B1 type adult neural stem cells. Cell Stem Cell.
5:515–526. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barrett LE, Granot Z, Coker C, Iavarone A,
Hambardzumyan D, Holland EC, Nam HS and Benezra R: Self-renewal
does not predict tumor growth potential in mouse models of
high-grade glioma. Cancer Cell. 21:11–24. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Salic A and Mitchison TJ: A chemical
method for fast and sensitive detection of DNA synthesis in vivo.
Proc Natl Acad Sci USA. 105:2415–2420. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yin M, Li X, Tan S, Zhou HJ, Ji W, Bellone
S, Xu X, Zhang H, Santin AD, Lou G and Min W: Tumor-associated
macrophages drive spheroid formation during early transcoelomic
metastasis of ovarian cancer. J Clin Invest. 126:4157–4173. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Guo P, Lan J, Ge J, Mao Q and Qiu Y: ID1
regulates U87 human cell proliferation and invasion. Oncol Lett.
6:921–926. 2013.PubMed/NCBI
|
|
28
|
Lai X, Liao J, Lin W, Huang C, Li J, Lin
J, Chen Q and Ye Y: Inhibitor of DNA-binding protein 1 knockdown
arrests the growth of colorectal cancer cells and suppresses
hepatic metastasis in vivo. Oncol Rep. 32:79–88. 2014.PubMed/NCBI
|
|
29
|
Damdinsuren B, Nagano H, Kondo M, Natsag
J, Hanada H, Nakamura M, Wada H, Kato H, Marubashi S, Miyamoto A,
et al: TGF-beta1-induced cell growth arrest and partial
differentiation is related to the suppression of Id1 in human
hepatoma cells. Oncol Rep. 15:401–408. 2006.PubMed/NCBI
|
|
30
|
Musgrove EA, Caldon CE, Barraclough J,
Stone A and Sutherland RL: Cyclin D as a therapeutic target in
cancer. Nat Rev Cancer. 11:558–572. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ahmad A, Aboukameel A, Kong D, Wang Z,
Sethi S, Chen W, Sarkar FH and Raz A: Phosphoglucose
isomerase/autocrine motility factor mediates epithelial-mesenchymal
transition regulated by miR-200 in breast cancer cells. Cancer Res.
71:3400–3409. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wells A, Yates C and Shepard CR:
E-cadherin as an indicator of mesenchymal to epithelial reverting
transitions during the metastatic seeding of disseminated
carcinomas. Clin Exp Metastasis. 25:621–628. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guo Q, Guo P, Mao Q, Lan J, Lin Y, Jiang J
and Qiu Y: ID1 affects the efficacy of radiotherapy in glioblastoma
through inhibition of DNA repair pathways. Med Oncol. 30:3252013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Romero-Lanman EE, Pavlovic S, Amlani B,
Chin Y and Benezra R: Id1 maintains embryonic stem cell
self-renewal by up-regulation of Nanog and repression of Brachyury
expression. Stem Cells Dev. 21:384–393. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chambers I, Colby D, Robertson M, Nichols
J, Lee S, Tweedie S and Smith A: Functional expression cloning of
Nanog, a pluripotency sustaining factor in embryonic stem cells.
Cell. 113:643–655. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ivanova N, Dobrin R, Lu R, Kotenko I,
Levorse J, DeCoste C, Schafer X, Lun Y and Lemischka IR: Dissecting
self-renewal in stem cells with RNA interference. Nature.
442:533–538. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Boyer LA, Lee TI, Cole MF, Johnstone SE,
Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG,
et al: Core transcriptional regulatory circuitry in human embryonic
stem cells. Cell. 122:947–956. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu L, Wei X, Ling J, Wu L and Xiao Y:
Expression pattern of Oct-4, Sox2 and c-Myc in the primary culture
of human dental pulp derived cells. J Endod. 37:466–472. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mitsui K, Tokuzawa Y, Itoh H, Segawa K,
Murakami M, Takahashi K, Maruyama M, Maeda M and Yamanaka S: The
homeoprotein Nanog is required for maintenance of pluripotency in
mouse epiblast and ES cells. Cell. 113:631–642. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Piestun D, Kochupurakkal BS, Jacob-Hirsch
J, Zeligson S, Koudritsky M, Domany E, Amariglio N, Rechavi G and
Givol D: Nanog transforms NIH3T3 cells and targets cell-type
restricted genes. Biochem Biophys Res Commun. 343:279–285. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lin YL, Han ZB, Xiong FY, Tian LY, Wu XJ,
Xue SW, Zhou YR, Deng JX and Chen HX: Malignant transformation of
293 cells induced by ectopic expression of human Nanog. Mol Cell
Biochem. 351:109–116. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lindgren AG, Natsuhara K, Tian E, Vincent
JJ, Li X, Jiao J, Wu H, Banerjee U and Clark AT: Loss of Pten
causes tumor initiation following differentiation of murine
pluripotent stem cells due to failed repression of Nanog. PLoS One.
6:e164782011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Bourillot PY, Aksoy I, Schreiber V, Wianny
F, Schulz H, Hummel O, Hubner N and Savatier P: Novel STAT3 target
genes exert distinct roles in the inhibition of mesoderm and
endoderm differentiation in cooperation with Nanog. Stem Cells.
27:1760–1771. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Golubovskaya VM: FAK and Nanog cross talk
with p53 in cancer stem cells. Anticancer Agents Med Chem.
13:576–580. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yang G, Zhang Y, Xiong J, Wu J, Yang C,
Huang H and Zhu Z: Downregulation of Id1 by small interfering RNA
in gastric cancer inhibits cell growth via the Akt pathway. Mol Med
Rep. 5:1075–1079. 2012.PubMed/NCBI
|
|
47
|
Ciarrocchi A, Jankovic V, Shaked Y, Nolan
DJ, Mittal V, Kerbel RS, Nimer SD and Benezra R: Id1 restrains p21
expression to control endothelial progenitor cell formation. PLoS
One. 2:e13382007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Zhang D and Fan D: Multidrug resistance in
gastric cancer: Recent research advances and ongoing therapeutic
challenges. Expert Rev Anticancer Ther. 7:1369–1378. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Jamieson ER and Lippard SJ: Structure,
recognition, and processing of cisplatin-DNA adducts. Chem Rev.
99:2467–2498. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Galluzzi L, Senovilla L, Vitale I, Michels
J, Martins I, Kepp O, Castedo M and Kroemer G: Molecular mechanisms
of cisplatin resistance. Oncogene. 31:1869–1883. 2012. View Article : Google Scholar : PubMed/NCBI
|
